EP2552480 - HIV VACCINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.06.2015 Database last updated on 12.10.2024 | Most recent event Tooltip | 19.06.2015 | Application deemed to be withdrawn | published on 22.07.2015 [2015/30] | Applicant(s) | For all designated states GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89 1330 Rixensart / BE | [N/P] |
Former [2013/06] | For all designated states GlaxoSmithKline Biologicals S.A. rue de l'Institut, 89 1330 Rixensart / BE | Inventor(s) | 01 /
BOURGUIGNON, Patricia GlaxoSmithKline Biologicals sa rue de l'Institut 89 B-1330 Rixensart / BE | 02 /
KOUTSOUKOS, Marguerite Christine GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 B-1330 Rixensart / BE | 03 /
LORIN, Clarisse GlaxoSmithKline Biologicals s.a. rue de I'Institut 89 B-1330 Rixensart / BE | 04 /
MCNALLY, Lisa GlaxoSmithKline 980 Great West Road Brenford Middlesex TW8 9GS / GB | 05 /
VOSS, Gerald Hermann GlaxoSmithKline Biologicals s.a. rue de I'Institut 89 B-1330 Rixensart / BE | [2013/06] | Representative(s) | West, Heloise, et al GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG / GB | [N/P] |
Former [2013/06] | West, Heloise, et al GlaxoSmithKline Global Patents CN9 25.1 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 11709973.9 | 25.03.2011 | WO2011EP54654 | Priority number, date | US20100318130P | 26.03.2010 Original published format: US 318130 P | [2013/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011117408 | Date: | 29.09.2011 | Language: | EN | [2011/39] | Type: | A1 Application with search report | No.: | EP2552480 | Date: | 06.02.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2011 takes the place of the publication of the European patent application. | [2013/06] | Search report(s) | International search report - published on: | EP | 29.09.2011 | Classification | IPC: | A61K39/21, A61P31/18 | [2013/06] | CPC: |
A61K39/21 (EP,KR,US);
A61K39/12 (EP,US);
A61K39/39 (KR);
A61P31/18 (EP);
A61P37/04 (EP);
A61K2039/55555 (EP,US);
A61K2039/55572 (EP,US);
A61K2039/57 (EP,US);
C07K2319/00 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/06] | Extension states | BA | 17.10.2012 | ME | 17.10.2012 | Title | German: | HIV-IMPFSTOFF | [2013/06] | English: | HIV VACCINE | [2013/06] | French: | VACCIN CONTRE LE HIV | [2013/06] | Entry into regional phase | 17.10.2012 | National basic fee paid | 17.10.2012 | Designation fee(s) paid | 17.10.2012 | Examination fee paid | Examination procedure | 17.10.2012 | Examination requested [2013/06] | 10.05.2013 | Amendment by applicant (claims and/or description) | 04.08.2014 | Despatch of a communication from the examining division (Time limit: M06) | 17.02.2015 | Application deemed to be withdrawn, date of legal effect [2015/30] | 13.03.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/30] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.08.2014 | Fees paid | Renewal fee | 08.03.2013 | Renewal fee patent year 03 | 10.03.2014 | Renewal fee patent year 04 | 06.03.2015 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2006013106 (GLAXOSMITHKLINE BIOLOG SA [BE], et al); | [XI]WO2008107370 (GLAXOSMITHKLINE BIOLOG SA [BE], et al); | [XI]WO2010023260 (GLAXOSMITHKLINE BIOLOG SA [BE], et al); | by applicant | GB2220211 | EP0362278 | EP0109942 | EP0468520 | WO9400153 | US5278302 | WO9421292 | WO9517210 | EP0671948 | WO9526204 | WO9633739 | US5666153 | EP0689454 | WO9815287 | WO9856414 | WO0007631 | WO2005107798 | WO2006013106 | US2010055166 | WO2010023260 |